(Q34626692)

3 August 2017

Immunohistochemical expression of BRCA1 and lethal prostate cancer (English)

1 reference

3 August 2017

1 reference

Richard Flavin

4

0 references

Stephen P. Finn

Stephen Finn

15

0 references

Katja Fall

Katja Fall

7

0 references

Jennifer R Stark

Jennifer Stark

5

0 references

Philip W. Kantoff

Philip W Kantoff

14

0 references

Lorelei A. Mucci

17

Lorelei Mucci

1 reference

3 August 2017

11

Edward Giovannucci

1 reference

3 August 2017

16

Massimo Loda

1 reference

3 August 2017

12

Meir Stampfer

1 reference

3 August 2017

Michelangelo Fiorentino

1

Michelangelo Fiorentino

1 reference

3 August 2017

2

Gregory Judson

1 reference

3 August 2017

6

Christopher Fiore

1 reference

3 August 2017

3

Kathryn Penney

1 reference

3 August 2017

10

Jennifer Sinnott

1 reference

3 August 2017

13

Howard D Sesso

1 reference

3 August 2017

Neil Martin

8

1 reference

3 August 2017

Jing Ma

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

13 April 2010

1 reference

3 August 2017

1 reference

3 August 2017

70

1 reference

3 August 2017

8

1 reference

3 August 2017

3136-3139

1 reference

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

The contribution of BRCA1 and BRCA2 to ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Common variation in the BRCA1 gene and prostate cancer risk.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

The role of BRCA1 in transcriptional regulation and cell cycle control

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

A randomized trial of aspirin and beta-carotene among U.S. physicians

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049266

BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20388772

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20388772

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20388772

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/0008-5472.CAN-09-4100

1 reference

3 August 2017

1 reference

3 August 2017

1 reference